Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phil Cheng

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
BMC Biology|December 2, 2015
Loss of Ezh2 promotes a midbrain-to-forebrain identity switch by direct gene derepression and Wnt-dependent regulationMartina Zemke, Kalina Draganova, Annika Klug, et al.
JID Innovations : Skin Science From Molecules to Population Health|January 27, 2025
DNA Methyltransferase Inhibition Upregulates the Costimulatory Molecule ICAM-1 and the Immunogenic Phenotype of Melanoma CellsAlessandra S P Cereghetti, Patrick Turko, Phil Cheng, et al.
Oncotarget|October 6, 2016
PARP1 inhibitor olaparib (Lynparza) exerts synthetic lethal effect against ligase 4-deficient melanomasMałgorzata Czyż, Monika Toma, Anna Gajos-Michniewicz, et al.
Cancer Research|December 28, 2017
Germinal Centers Determine the Prognostic Relevance of Tertiary Lymphoid Structures and Are Impaired by Corticosteroids in Lung Squamous Cell CarcinomaKarīna Siliņa, Alex Soltermann, Farkhondeh Movahedian Attar, et al.
European Journal of Cancer (Oxford, England : 1990)|July 15, 2023
Diagnostic performance of augmented intelligence with 2D and 3D total body photography and convolutional neural networks in a high-risk population for melanoma under real-world conditions: A new era of skin cancer screening?Sara E Cerminara, Phil Cheng, Lisa Kostner, et al.
Nature Communications|January 23, 2015
The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressorsDaniel Zingg, Julien Debbache, Simon M Schaefer, et al.
Plos Genetics|January 29, 2015
Antagonistic cross-regulation between Sox9 and Sox10 controls an anti-tumorigenic program in melanomaOlga Shakhova, Phil Cheng, Pravin J Mishra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2017
Inhibition of Age-Related Therapy Resistance in Melanoma by Rosiglitazone-Mediated Induction of KlothoReeti Behera, Amanpreet Kaur, Marie R Webster, et al.
Cancers|November 9, 2024
Adjuvant Use of Pembrolizumab for Stage III Melanoma in a Real-World Setting in EuropeMichael Weichenthal, Joanna Mangana, Iva Gavrilova, et al.
Cell|May 9, 2024
Circadian tumor infiltration and function of CD8<sup>+</sup> T cells dictate immunotherapy efficacyChen Wang, Qun Zeng, Zeynep Melis Gül, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
BMC Biology|December 2, 2015
Loss of Ezh2 promotes a midbrain-to-forebrain identity switch by direct gene derepression and Wnt-dependent regulationMartina Zemke, Kalina Draganova, Annika Klug, et al.
JID Innovations : Skin Science From Molecules to Population Health|January 27, 2025
DNA Methyltransferase Inhibition Upregulates the Costimulatory Molecule ICAM-1 and the Immunogenic Phenotype of Melanoma CellsAlessandra S P Cereghetti, Patrick Turko, Phil Cheng, et al.
Oncotarget|October 6, 2016
PARP1 inhibitor olaparib (Lynparza) exerts synthetic lethal effect against ligase 4-deficient melanomasMałgorzata Czyż, Monika Toma, Anna Gajos-Michniewicz, et al.
Cancer Research|December 28, 2017
Germinal Centers Determine the Prognostic Relevance of Tertiary Lymphoid Structures and Are Impaired by Corticosteroids in Lung Squamous Cell CarcinomaKarīna Siliņa, Alex Soltermann, Farkhondeh Movahedian Attar, et al.
European Journal of Cancer (Oxford, England : 1990)|July 15, 2023
Diagnostic performance of augmented intelligence with 2D and 3D total body photography and convolutional neural networks in a high-risk population for melanoma under real-world conditions: A new era of skin cancer screening?Sara E Cerminara, Phil Cheng, Lisa Kostner, et al.
Nature Communications|January 23, 2015
The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressorsDaniel Zingg, Julien Debbache, Simon M Schaefer, et al.
Plos Genetics|January 29, 2015
Antagonistic cross-regulation between Sox9 and Sox10 controls an anti-tumorigenic program in melanomaOlga Shakhova, Phil Cheng, Pravin J Mishra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2017
Inhibition of Age-Related Therapy Resistance in Melanoma by Rosiglitazone-Mediated Induction of KlothoReeti Behera, Amanpreet Kaur, Marie R Webster, et al.
Cancers|November 9, 2024
Adjuvant Use of Pembrolizumab for Stage III Melanoma in a Real-World Setting in EuropeMichael Weichenthal, Joanna Mangana, Iva Gavrilova, et al.
Cell|May 9, 2024
Circadian tumor infiltration and function of CD8<sup>+</sup> T cells dictate immunotherapy efficacyChen Wang, Qun Zeng, Zeynep Melis Gül, et al.
Pageof 4